Shields Matthew 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 7, 2025
Insider Transaction Report
Form 4
Shields Matthew
EVP, Global Operations
Transactions
- Award
Restricted Share Units
2025-03-05+69,182→ 69,182 total→ Ordinary Shares (69,182 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on March 5, 2025, with 17,295 vesting on each of March 5, 2026, March 5, 2027 and March 5, 2028, and 17,297 vesting on March 5, 2029.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.